|
| |
| | | 67648 | | 26.04.2021 | | Novartis Pharma Schweiz AG | | | | | | | 06.03.2028 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tabrecta 150 mg | Filmtabletten | Coated tablets (Capmatinibum 150 mg) | L01EX17 | CI | | 02 | Tabrecta 200 mg | Filmtabletten | Coated tablets (Capmatinibum 200 mg) | L01EX17 | CI |
|
|
|